Medical Procedure News

RSS

Samson Hair Restoration inaugurates new facility in San Diego

Samson Hair Restoration is opening a San Diego area facility located in Cardiff, California due to increased demand of their services. Samson Hair Restoration is an innovative hair restoration company with proprietary design techniques. This is its second surgical location in Southern California.

27 Apr 2011

Advanced Orthopaedics & Spine Medicine to participate in iUni G2 knee implant trial

Dr. David Mack of Advanced Orthopaedics & Spine Medicine and North Cypress Medical Center are participating in a ten year follow-up trial of the ConforMIS iUni® G2 knee resurfacing device, an FDA cleared implant for patients with osteoarthritic damage in a single compartment of the knee.

27 Apr 2011

Performance Orthopedics to participate in iUni G2 knee implant trial

Dr. Gregory Martin of Performance Orthopedics of the Palm Beaches is participating in a ten year follow-up trial of the ConforMIS iUni G2 knee resurfacing device, an FDA cleared implant for patients with osteoarthritic damage in a single compartment of the knee.

27 Apr 2011

MAQUET introduces new pediatric oxygenators and reservoirs in the U.S.

MAQUET Cardiovascular today announced the launch of its QUADROX-i Neonatal and Pediatric oxygenators and reservoirs in the United States. Oxygenators are an integral part of a cardiopulmonary bypass system and function as an artificial lung during surgical procedures.

27 Apr 2011

ISCO completes first series of hepatocytes preclinical testing

International Stem Cell Corporation announces successful completion of the first series of preclinical testing of hepatocytes derived in the lab from human parthenogenetic stem cells.

27 Apr 2011

BioInvent, ThromboGenics initiate TB-402 Phase IIb trial for VTE prophylaxis

ThromboGenics NV and co-development partner BioInvent International announce today that the first patient has been dosed in a Phase IIb trial with their novel long-acting anticoagulant TB-402 for the prophylaxis of venous thromboembolism after total hip surgery.

27 Apr 2011

Brookside Surgery Center to participate in iUni G2 knee implant trial

Dr. Joseph Burkhardt of Brookside Surgery Center is participating in a ten year follow-up trial of the ConforMIS iUni G2 knee resurfacing device, an FDA cleared implant for patients with osteoarthritic damage in a single compartment of the knee.

27 Apr 2011

Tarix begins patient enrollment for TXA127 Phase 1 study in DCBT

Tarix Pharmaceuticals today announced enrollment of the first patient in a Phase 1 clinical study of TXA127, a pharmaceutical grade formulation of a naturally occurring peptide known to stimulate early hematopoietic precursor cells in the bone marrow.

27 Apr 2011

FDA clears Biomet's Active Articulation Hip System

Biomet, Inc., a global leader in the manufacture of orthopedic and biotechnology products, today announced clearance of its Active Articulation E1 Dual Mobility Hip System, by the United States Food and Drug Administration.

27 Apr 2011

Hair transplant robot gets FDA nod

The United States regulator, Food and Drugs Administrator (FDA) has approved a machine called the Artas System for commercial use. According to manufacturers Restoration Robotics, Artas is “an interactive, computer assisted system utilizing image-guided robotics to enhance the quality of hair follicle harvesting” by combining “several features including an interactive, image-guided robotic arm, special imaging technologies, small dermal punches and a computer interface.” Artas can be used only on patients with straight brown or black hair at this stage.

26 Apr 2011

Botox injections: Reading and mimicking emotions hampered

In cosmetics, a Botox injection, consisting of a small dose of botulinum toxin, can be used to prevent formation of wrinkles by paralyzing facial muscles and can therefore make users appear less emotional. Now a new study finds that the cosmetic toxin may also make recipients less able to read the emotions of others.

26 Apr 2011

MRI referrals determined by loyalty to unit rather than patient choice

Referrers were found to have a strong sense of loyalty to external medical units, with almost eight per cent saying that they had used the same MRI provider for over 25 years. Clinicians, who identified location, staff expertise and scanner quality as key reasons for initially referring patients, said they were difficult to influence thereafter.

26 Apr 2011

New nano-systems capable of binding heparin as effectively as protamine

New nano-systems developed in York may eventually help patients recover from surgery without the danger of allergic reactions to drugs.

26 Apr 2011

FDA clears Sound Surgical's new PowerX Lipo System

Sound Surgical Technologies, a leading manufacturer and distributor of body shaping technologies, announced today that the PowerX Lipo System has been cleared for use by the Food and Drug Administration.

26 Apr 2011

FDA clears Reverse Medical's ReFlex Catheter for neurovascular procedure

Reverse Medical Corporation announced today that it has received US FDA 510k clearance to market the ReFlex line of intracranial catheters for distal neurovascular access and microcatheter therapeutic delivery.

26 Apr 2011

Multipolar electrocoagulation is a safe, effective therapy for Barrett's esophagus

A new study reports that multipolar electrocoagulation in combination with acid suppression is a safe and effective method to ablate nondysplastic Barrett's esophagus over the long term.

26 Apr 2011

Patients of orthopedists are more apt to undergo back surgery

When doctors own or lease MRI equipment, their patients are more likely to receive scans for low back pain. Patients of orthopedists are more apt to undergo back surgery as well, according to a study published online in Health Services Research.

26 Apr 2011

BMY to present belatacept Phase III new data at American Transplant Congress

New data on belatacept, an investigational selective T cell costimulation blocker being studied for use in renal transplantation by Bristol-Myers Squibb Company, will be presented at the American Transplant Congress April 30 - May 4, 2011 in Philadelphia.

26 Apr 2011

SI-BONE receives FDA approval for updated iFuse Implant System

SI-BONE, Inc., a medical device company that is pioneering the use of a minimally invasive surgical device to treat the sacroiliac joint announced the U.S. Food and Drug Administration approved a major modification to the existing product label.

26 Apr 2011

Boston Scientific launches ION Paclitaxel-Eluting Platinum Chromium Coronary Stent System

Boston Scientific Corporation today announced U.S. Food and Drug Administration (FDA) approval and launch of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System, the Company's third-generation drug-eluting stent technology.

25 Apr 2011